Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome. [electronic resource]
Producer: 20070508Description: 332-3 p. digitalISSN:- 0361-8609
- Antineoplastic Agents -- adverse effects
- Arsenic Trioxide
- Arsenicals -- adverse effects
- Cell Differentiation -- drug effects
- Humans
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Oxides -- adverse effects
- Pulmonary Alveoli -- drug effects
- Respiratory Distress Syndrome -- chemically induced
- Syndrome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.